Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multicentre phase 3 trial. (Record no. 27475752)

MARC details
000 -LEADER
fixed length control field 02298 a2200673 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517170901.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201710s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1474-4457
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/S1473-3099(17)30496-6
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Forns, Xavier
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20171002
245 00 - TITLE STATEMENT
Title Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multicentre phase 3 trial.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. The Lancet. Infectious diseases
Date of publication, distribution, etc. 10 2017
300 ## - PHYSICAL DESCRIPTION
Extent 1062-1068 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged, 80 and over
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aminoisobutyric Acids
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antiviral Agents
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Benzimidazoles
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cyclopropanes
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Therapy, Combination
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Genotype
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hepacivirus
General subdivision classification
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hepatitis C
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lactams, Macrocyclic
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Leucine
General subdivision analogs & derivatives
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Liver Cirrhosis
General subdivision complications
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Proline
General subdivision analogs & derivatives
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pyrrolidines
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Quinoxalines
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Sulfonamides
General subdivision administration & dosage
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lee, Samuel S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Valdes, Joaquin
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lens, Sabela
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ghalib, Reem
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Aguilar, Humberto
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Felizarta, Franco
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hassanein, Tarek
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hinrichsen, Holger
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Rincon, Diego
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Morillas, Rosa
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Zeuzem, Stefan
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Horsmans, Yves
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Nelson, David R
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Yu, Yao
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Krishnan, Preethi
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lin, Chih-Wei
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kort, Jens J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Mensa, Federico J
773 0# - HOST ITEM ENTRY
Title The Lancet. Infectious diseases
Related parts vol. 17
-- no. 10
-- p. 1062-1068
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/S1473-3099(17)30496-6">https://doi.org/10.1016/S1473-3099(17)30496-6</a>
Public note Available from publisher's website

No items available.